Clinical Trial Update: A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US) [Phase 2]

View source ↗

Summary

A completed Phase 2 long-term trial evaluating SPP100 for essential hypertension; the study is not recruiting in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SPP100

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 2 | Status: COMPLETED